Главная страницаLBank Stocks
LeonaBio, Inc.
LeonaBio, Inc.

LeonaBio, Inc. (LONA)

24HВысокий$5.7224HНизкий$4.51
$5.58
+0.17%

Последнее обновление: 2026-10-06 11:01:46

Симуляция графика K-линий, фактические данные указаны на торговой странице

Ключевые данные

Открытие вчера
$4.75
Пред. закрытие
$5.58
Вчерашний диапазон
$4.51 - $5.72
Диапазон 52 нед.
$2.21 - $14.21
Объем торговли
270.538K
МС
$45.412M
P/E
--
EPS
$-23.01

Обзор компании

NASDAQ

LeonaBio, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company is headquartered in Bothell, Washington.

СекторHEALTHCARE
ОтрасльBIOTECHNOLOGY
Штаб-квартира18706 NORTH CREEK PARKWAY, BOTHELL, WA, UNITED STATES, 98011
СтранаUSA
Дата листинга2020-09-18
Конец финансового года2026-06-30
Акции в обращении9.422M
Код CIK1620463

Финансовые показатели

Индикатор2026-03-312025-12-312025-09-302025-06-30
Доход$0$0$0$0
Операционные расходы--$68.088M$243K$200K
Чистая прибыль-$32.948M-$82.889M-$6.611M-$6.966M
Чистая рентабельность--------
Прибыль на акцию$-7.71$-19.39$-1.68$-0.18
EBITDA-$17.214M-$78.324M-$6.503M-$6.766M
Эффективная налоговая ставка--------

Часто задаваемые вопросы

LONA operates within the [sector] sector and is focused on [core business]. Its main activity involves [core business details], which positions it as a significant player in its industry.
LONA generates most of its revenue from [main revenue drivers], leveraging its expertise in [sector/industry]. This focus allows the company to maintain a competitive edge and sustain financial performance.
As with any investment, there are risks. For LONA, these could include [list key risks, e.g., industry volatility, competition, regulatory impacts]. Investors should carefully evaluate these factors before making decisions.
LONA competes with companies such as [competitor names], distinguishing itself through [specific strengths, e.g., product offering, market share]. However, competition remains strong, posing challenges and opportunities.
Yes/No, LONA [does/does not] pay dividends. Its dividend policy reflects [focus on reinvestment, income distribution]. Investors interested in dividend income should consider this when evaluating the company.
LONA has opportunities in [growth areas, e.g., emerging markets, new technologies]. By leveraging [its strengths], the company is positioned to capitalize on sector trends, though risks remain.
LONA's financial performance may be influenced by [factors such as economic conditions, shifts in demand, input costs]. External and internal elements both play a role in its profitability and overall operations.
Based on current market data, LONA's valuation metrics such as P/E ratio, market cap, and revenue are in line with/above/below its peers like [competitor names]. Valuation reflects both strengths and market challenges.
Предупреждение о рисках
  1. 1.Цены на акции могут сильно колебаться, инвестируйте осторожно. Прошлые результаты не гарантируют будущую доходность.
  2. 2.Торговля цифровыми активами сопряжена с рыночными, техническими и иными рисками. Пожалуйста, принимайте взвешенные решения и рационально распределяйте активы.
  3. 3.Информация на этой странице предназначена только для ознакомления и не является инвестиционной рекомендацией.